NEW YORK, NY--(Marketwire - August 17, 2010) -
| Highlighted Links |
|
Optigenex Inc. (PINKSHEETS: OPGX) announced today a broad expansion of licensing rights granted to Promethean Corporation for the manufacture, distribution and marketing of branded dietary supplements and oral and topical cosmecuetical products containing AC-11®, a patented, all-natural rain forest botanical extract manufactured by Optigenex. Under the terms of the parties’ new alliance, Promethean, through its wholly owned subsidiary, Ceres Living, will reach out to new markets with its acclaimed “AIO Premium Cellular Health™" line of advanced dietary supplements containing AC-11®, and will increase focus on developing a global sales initiative for specially formulated next generation topical skin care products with AC-11®. AC-11® is a unique proprietary ingredient that helps the body’s natural ability to repair damaged DNA as a result of overexposure to the sun and other environmental stressors. The new contract greatly enlarges the scope of Promethean’s “territory” for marketing AC-11® products beyond the North American distribution channels that formed the major portion of the parties’ initial relationship beginning in 2009. Promethean will now have the right to promote its AC-11® product lines worldwide, except in Japan and Turkey, and will enjoy expanded exclusivity in certain channels and countries.
Daniel Zwiren, president and CEO of Optigenex Inc., said, “From the start last year, our company’s association with Promethean and Ceres Living has been special. Finding a way to expand our interactions into something more akin to a product development and marketing partnership than a supplier-customer relationship was something we at Optigenex realized early on should be a priority goal. I am pleased to see that we were able to achieve the goal so quickly, and to know that the AC-11® brand and our unique message of DNA health will now receive the highest possible level of global exposure with Promethean.”
Matthew Henninger, Chairman & CEO of Promethean Corporation, commented, “We are thrilled with the growth of our ‘Development Partner’ relationship with Optigenex. Our companies have been working very closely in the research and development of cutting edge products. The expansion of our relationship provides our companies with the comfort of long term commitment for growth worldwide.”
About Optigenex Inc.:
Optigenex Inc. is a technology-based developer of proprietary anti-aging ingredients for various health-related industries, including wellness, beauty and dietary supplements. AC-11® (formerly known as C-MED-100®) is the company’s patented all-natural extract from the medicinal herb Uncaria tomentosa. From its origins in the Amazon Rain Forest, AC-11® delivers a unique bioactive compound of water soluble carboxy alkyl esters (CAEs™) that form the backbone of the company’s revolutionary approach to DNA care and healthy aging. For more information about Optigenex please visit our website: www.optigenex.com
About Promethean Corporation:
Promethean Corp. (“Promethean”) is a New York City based Health Care related products and services company that develops, manufactures and distributes its own products. The company through its wholly owned subsidiary, Ceres Living, produces and sells the AIO Premium Cellular Health™ product line. The company develops Advanced Nutraceuticals, Advanced Personal Care products and other Nutritional and Wellness Products and Services that it may sell or sells in multiple channels of distribution. For more information about Promethean Corporation, please contact the company at (212)-355-5129.
*The statements made in this press release have not been evaluated by the Food and Drug Administration (FDA). The products mentioned herein are not intended to treat, diagnose, cure or prevent any disease.
For more information:
Optigenex Inc.
www.optigenex.com
